Top 100 Brands Account for 21% of Total FMCG E-commerce Value: Euromonitor International Private label brand sales accounted for 25% of top 100 ranked brand sales Proprietary direct-to-consumer model thrives amid shifting landscape Global demand for premium products persists
ViiV Healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir Initial data from the CLARITY study are first to compare acceptability and tolerability of single-dose cabotegravir (CAB) and lenacapavir (LEN) long-acting injections, in 63 HIV-negative adults Sixty-nine percent of individuals found CAB injections to be ‘totally or very acceptable’ versus 48% for LEN injections, and 90% of participants and 86% of healthcare providers preferred CAB injections over LEN Findings could help inform expectations and decision-making when initiating long-acting HIV injectables
Cybersecurity Tops CFO’s Risk Agenda With 99% Reporting Incidents and 94% Planning to Increase Spend Nearly every UK CFO surveyed (99%) has faced a payments-related cyber incident in the past two years1, with cybersecurity now their number one operational risk. Appetite for automation is universal with Accounts Payable the top priority, but integration challenges with existing systems keep finance leaders exposed and inefficient. Real-time oversight is seen as essential, yet only 64% of those surveyed are confident that their systems can deliver it2 – highlighting the need for modernised, unified solutions.